Capitol Health Ltd (ASX: CAJ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Capitol Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $291.82 million
P/E Ratio 22.08
Dividend Yield 3.51%
Shares Outstanding 1.04 billion
Earnings per share 0.013
Dividend per share 0.01
Year To Date Return -25.64%
Earnings Yield 4.53%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Capitol Health Ltd (ASX: CAJ)
Latest News

A woman sits at her computer with hand to mouth and a contemplative smile on her face although she is considering or thinking about information she is seeing on the screen.
Broker Notes

Brokers rate these 2 top ASX shares as buys in May 2022

Elmo and Capitol Health are two ASX shares brokers are liking.

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Small Cap Shares

3 small-cap ASX shares that pay big dividends? Please tell me more

The small end of the market is back in town.

Read more »

Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
Share Gainers

These 3 ASX healthcare shares are soaring today. Why?

Forget the broad market today -- these 3 ASX healthcare shares have each outpaced their peers and landed firmly in…

Read more »

View from above of two young contemporary people shaking hands, agreeing to the deal.
⏸️ ASX Shares

2 ASX shares this fund manager considers possible targets in the M&A frenzy

Mergers and acquisitions are on fire at the moment. Which ASX shares could be in the crosshairs next?

Read more »

1851 Capital's Martin Hickson, Mary-Ann Baldock, and Chris Stott
Ask a Fund Manager

8 ASX shares that supercharged us out of COVID-19: analyst

Ask A Fund Manager: 1851 Capital's Martin Hickson reveals how he took full advantage of the government's pandemic stimulus.

Read more »

ASX shares fund manager martin hickson
Ask a Fund Manager

Why we avoid mining and biotech ASX shares: fund manager

Ask A Fund Manager: 1851 Capital's Martin Hickson also reveals the telecommunications company that gets paid to build its products.

Read more »

A drawing of a white rocket streaking up, indicating a surging share pirce movement
Small Cap Shares

3 top ASX small cap shares that delivered for this fund’s portfolio

The 1851 Emerging Companies Fund has outlined three ASX shares that really delivered for the portfolio in March 2021.

Read more »

buy and hold
⏸️ ASX Shares

2 top ASX shares to buy according to WAM

Fund manager Wilson Asset Management (WAM) has unveiled two ASX shares that it likes, including Capitol Health Ltd (ASX:CAJ).

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
03 Mar 2022 $0.0050 100.00% Interim 01 Apr 2022
23 Sep 2021 $0.0050 100.00% Final 22 Oct 2021
04 Mar 2021 $0.0050 100.00% Interim 01 Apr 2021
24 Sep 2020 $0.0050 100.00% Final 23 Oct 2020
05 Mar 2020 $0.0050 100.00% Interim 23 Oct 2020
24 Sep 2019 $0.0050 100.00% Final 23 Oct 2019
05 Mar 2019 $0.0050 100.00% Interim 03 Apr 2019
26 Sep 2018 $0.0040 100.00% Final 25 Oct 2018
02 Mar 2018 $0.0040 100.00% Interim 03 Apr 2018
23 Sep 2015 $0.0065 100.00% 23 Oct 2015
25 Mar 2015 $0.0060 100.00% 24 Apr 2015
24 Sep 2014 $0.0050 100.00% Final 24 Oct 2014
24 Mar 2014 $0.0040 100.00% Interim 24 Apr 2014
23 Sep 2013 $0.0030 100.00% Final 25 Oct 2013
22 Mar 2013 $0.0025 100.00% Interim 26 Apr 2013
24 Sep 2012 $0.0020 100.00% Final 19 Oct 2012
04 Apr 2012 $0.0020 100.00% Interim 20 Apr 2012

CAJ ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Capitol Health Ltd

Capitol Health Ltd is a provider of diagnostic imaging and related services to the Australian healthcare market. The firm has one business segment which is the operation of diagnostic imaging facilities in Australia. Geographically, it operates only in Australia. It generates its revenue from diagnostic imaging services. The company's offerings include X-Ray, Ultrasound, CT and MRIs, nuclear medicine, mammography/breast screen, bone densitometry, and other related services.

CAJ Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 Jul 2022 $0.28 $0.00 0.00% 265,847 $0.29 $0.29 $0.28
04 Jul 2022 $0.29 $-0.01 -3.39% 409,679 $0.30 $0.30 $0.29
01 Jul 2022 $0.30 $0.02 7.14% 2,192,850 $0.29 $0.30 $0.28
30 Jun 2022 $0.28 $0.01 3.64% 356,250 $0.28 $0.29 $0.28
29 Jun 2022 $0.28 $0.00 0.00% 210,073 $0.28 $0.29 $0.28
28 Jun 2022 $0.28 $0.01 3.70% 997,330 $0.28 $0.29 $0.27
27 Jun 2022 $0.27 $0.00 0.00% 1,632,075 $0.27 $0.28 $0.27
24 Jun 2022 $0.27 $0.00 0.00% 1,370,411 $0.28 $0.28 $0.27
23 Jun 2022 $0.27 $-0.01 -3.57% 1,948,765 $0.28 $0.28 $0.27
22 Jun 2022 $0.28 $0.01 3.70% 69,035 $0.28 $0.28 $0.27
21 Jun 2022 $0.27 $0.00 0.00% 306,881 $0.28 $0.28 $0.27
20 Jun 2022 $0.27 $-0.01 -3.57% 455,806 $0.29 $0.29 $0.27
17 Jun 2022 $0.28 $0.00 0.00% 3,791,915 $0.30 $0.30 $0.27
16 Jun 2022 $0.28 $-0.02 -6.67% 442,118 $0.30 $0.30 $0.28
15 Jun 2022 $0.30 $0.00 0.00% 569,301 $0.30 $0.30 $0.29
14 Jun 2022 $0.30 $-0.01 -3.28% 819,641 $0.29 $0.30 $0.29
10 Jun 2022 $0.31 $0.00 0.00% 546,406 $0.31 $0.31 $0.30
09 Jun 2022 $0.31 $0.01 3.33% 630,229 $0.30 $0.31 $0.30
08 Jun 2022 $0.30 $0.00 0.00% 629,584 $0.31 $0.31 $0.29
07 Jun 2022 $0.30 $0.00 0.00% 3,424,672 $0.30 $0.31 $0.30

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
16 Nov 2021 Justin Walter Issued 1 $734,126
Issue of securities. 7,335,509 - Performance Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Andrew Demetriou Non-Executive ChairmanNon-Executive Director Nov 2014
Mr Demetriou was Chief Executive Officer of the Australian Football League from 2003 until June 2014. He was the Managing Director of the Ruthinium Group, a dental implant business, and he currently remains a board member. He has also served as Non-Executive Chairman of the Baxter Group, is a former Chairman of the Australian Multicultural Advisory Council and served 2 years on the Referendum Council on behalf of the Federal Government for Indigenous Recognition in the Constitution. He was also the Chairman of Board of Management, Cox Architecture until December 2020. He is a member of Risk committee.
Mr Justin Samuel Walter Chief Executive OfficerManaging Director Jul 2019
Mr Walter has over thirty years of experience in healthcare across public and private hospitals, GP and allied health clinics, and consulting along with strong management and leadership skills. He was most recently Managing Director of ASX listed healthcare company Zenitas Healthcare, and has held senior roles managing hospitals for Healthscope, and Spotless Group's health sector.
Ms Laura Nicole McBain Non-Executive Director Jul 2021
Ms McBain was the CEO and Managing Director of ASX listed Bellamys Australia Ltd from 2014 to 2017, prior to which she was CEO / General Manager since 2007. Prior to joining Bellamys, Laura practiced as an accountant in both Sydney and Tasmania. Laura was also the Managing Director of Maggie Beer Holdings from 2017 to 2019 and former Non-Executive Director of Export Finance Australia from 2014 to 2020. She is currently a Strategic Consultant for the food and formula industry, and a Non-Executive Director for ASX listed Lark Distilling Ltd (ASX: LRK). In 2013, Laura was named Telstra Tasmanian Businesswoman of the Year and went on to be named the Telstra Australian Business Woman of the Year for 2013 (Private and Corporate).
Mr Richard John Loveridge Non-Executive Director Sep 2017
Mr Loveridge served as a partner in the Corporate Group of Herbert Smith Freehills for more than 20 years and was Managing Partner of their National Corporate Group for 5 years. Mr Loveridge's experience includes capital raisings, mergers and acquisitions, joint ventures, shareholder agreements, company reorganisations, and corporate head office and advisory matters. He is Chair of Risk committee.
Dr Kevin (Kai-Chung) Shaw Non-Executive Director Sep 2021
Dr Shaw has training and experience in neuroradiology and musculoskeletal imaging. He is the current Director of Radiology and Nuclear Medicine atthe University Hospital, Barwon Health. He has completed his radiology training at Royal Melbourne Hospital. Dr Shaw is a Clinical Associate Professor at Deakin Medical School and holds an honorary position with University of Melbourne where he participates in the Victorian radiology registrar teaching program. He is a past examiner for the Royal Australian and New Zealand College of Radiologists (RANZCR) and previously sat on the College's Anatomy Exam Review Panel. He has been an MRI Clinical Reviewer for the College since 2014. Dr Shaw currently sits on the Barwon Health, Medical Advisory Committee, Technology / Clinical Practice Committee and Mortality Committee. He is a councillor for Australian Medical Association Victoria as the State Representative for RANZCR.
Ms Melanie Jaye Leydin Company Secretary Aug 2017
-
Mr C Bremner Chief Financial Officer
-
Mr G Hughes Chief Operating Officer
-
Melanie Jaye Leydin Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Citicorp Nominees Pty Limited 175,231,262 17.08%
National Nominees Limited 149,997,447 14.62%
HSBC Custody Nominees (Australia) Limited 131,428,169 12.81%
J P Morgan Nominees Australia Pty Limited 121,140,086 11.81%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 55,741,837 5.43%
BNP Paribas Nominees Pty Ltd <DRP> 38,664,825 3.77%
Idinoc Pty Ltd <J & R Conidi Family A/C> 27,477,886 2.68%
HSBC Custody Nominees (Australia) Limited <NT Comwlth Super Corp A/C> 20,365,218 1.99%
Neweconomy Com Au Nominees Pty Limited <900 Account> 12,511,492 1.22%
Nick Conidi Pty Ltd <Conidi Family A/C> 11,764,740 1.15%
Gia Chau Pty Ltd 11,000,000 1.07%
Cs Third Nominees Pty Limited <HSBC Cust Nom Au Ltd 13 A/C> 9,623,821 0.94%
SMKA Super Pty Ltd <SK Super Fund A/C> 7,001,313 0.68%
UBS Nominees Pty Ltd 6,174,057 0.60%
Mr Nicola Conidi + Mrs Giannia Conidi <Nick & Jan Conidi S/F A/C> 6,160,486 0.60%
Stelhaven SMSF Pty Ltd <Stelhaven Super Fund A/C> 5,120,843 0.50%
Teleah Pty Ltd <Jr Sauvey Super Fund A/C> 4,177,946 0.41%
J & P Chick Pty Limited <J & P Chick Pty Ltd S/F A/C> 4,050,000 0.39%
Mr Andrew Duncan Harrison + Mrs Katrina Ellen Harrison <Harrison Super Fund A/C> 3,626,818 0.35%
Dr Jeffrey Eric Dale Chick + Dr Pamela Hazel Chick 3,518,000 0.34%

Profile

since

Note